The oral dosage form of Anrotinib is Anrotinib Hydrochloride Capsules, which has not been the subject of systematic drug-drug interaction studies, but does not usually conflict with herbal medications.
Anrotinib hydrochloride capsules have not been formally studied for drug interactions, but CYP3A/5 inducers such as rifampicin and CYP1A2 inducers such as montelukast may accelerate the metabolism of the product and decrease its plasma concentration, so try to avoid taking it together with the product.
Anrotinib has a moderately strong inhibitory effect on CYP2B6, CYP2C19, etc., and does not have a significant inducing effect on CYP3A4, etc., so it is also important to avoid taking this product together with a narrow therapeutic range of medications that undergo metabolism by these enzymes.
The instructions of this product have not explicitly mentioned that this product will conflict with traditional Chinese medicine, so it is usually possible to follow the doctor’s advice to take together.
It is recommended that patients go to the regular hospital for medical treatment when they feel sick, and follow the doctor’s instructions for symptomatic treatment, not self-medication, and consult with a doctor or pharmacist before taking it together with other medicines.